clinical trial · NCT07768891
Beclometasone Dipropionate and Formoterol Inhalation Aerosol for Asthma
Lunan Better Pharmaceutical Co., LTD.·phase3·recruiting·n = 416
Asthma (Diagnosis)Beclometasone Dipropionate and Formoterol Inhalation AerosolFOSTER®
brief summary
A multicenter, randomized, double-blind, active-controlled, parallel-group Phase III clinical study comparing the efficacy and safety of Beclometasone Dipropionate and Formoterol Inhalation Aerosol versus FOSTER® in patients with asthma. The purpose of this study is to compare the efficacy and safety of the Beclomethasone Dipropionate and Formoterol Fumarate inhalation aerosol (manufactured by Lunan Better Pharmaceutical Co., Ltd.) with FOSTER® in the treatment of patients with asthma.
started
Jun 8, 2026
primary completion
Jun 1, 2028
completion
Jun 1, 2028
last updated
Aug 17, 2026
official title
A Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel-Group Phase III Clinical Study Comparing the Efficacy and Safety of Beclometasone Dipropionate and Formoterol Inhalation Aerosol Versus FOSTER® in Patients With Asthma.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol